Business Description
Blueberries Medical Corp
NAICS : 325412
SIC : 3741
ISIN : CA09609Y1016
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 3.28 | |||||
Debt-to-EBITDA | -2.14 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -10.86 | |||||
Beneish M-Score | -4.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 62.7 | |||||
3-Year EPS without NRI Growth Rate | 49.2 | |||||
3-Year FCF Growth Rate | 51.9 | |||||
3-Year Book Growth Rate | -52.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.12 | |||||
9-Day RSI | 56.29 | |||||
14-Day RSI | 53.13 | |||||
12-1 Month Momentum % | -31.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 168.94 | |||||
Days Sales Outstanding | 101.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.8 | |||||
Shareholder Yield % | -0.24 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38.6 | |||||
Operating Margin % | -422.46 | |||||
Net Margin % | -438.25 | |||||
FCF Margin % | -480.71 | |||||
ROE % | -164.34 | |||||
ROA % | -44.03 | |||||
ROIC % | -46.53 | |||||
ROC (Joel Greenblatt) % | -66.41 | |||||
ROCE % | -93.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 25 | |||||
PB Ratio | 12.5 | |||||
EV-to-EBIT | -8.19 | |||||
EV-to-EBITDA | -9.34 | |||||
EV-to-Revenue | 24.59 | |||||
EV-to-FCF | -8.02 | |||||
Earnings Yield (Greenblatt) % | -12.21 | |||||
FCF Yield % | -22.84 |